β2-glycoprotein I inhibits vascular endothelial growth factor-induced angiogenesis by suppressing the phosphorylation of extracellular signal-regulated kinase 1/2, Akt, and endothelial nitric oxide synthase

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Chiu, Wen Chin ^a,b   Chiou, Tzeon Jye ^c   Chung, Meng Ju ^a   Chiang, An Na ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; AORTIC ENDOTHELIAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; AORTA; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHOSPHORYLATION;

ANIMALS; AORTA; BETA 2-GLYCOPROTEIN I; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84990224963     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161950     Document Type: Article

References (62)

1. Polz E, Kostner GM. The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett. 1979; 102: 183-186. PMID: 222615
2. 2-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 1999; 18: 5166-5174. PMID: 10508150
3. Kato H, Enjyoji K. Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: The presence of five Sushi domains. Biochemistry. 1991; 30: 11687-11694. PMID: 1751487
4. Yasuda S, Tsutsumi A, Chiba H, Yanai H, Miyoshi Y, Takeuchi R, et al. Beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis. 2000; 152: 337-346. PMID: 10998461
5. Takeuchi R, Atsumi T, Ieko M, Takeya H, Yasuda S, Ichikawa K, et al. Coagulation and fibrinolytic activities in 2 siblings with beta(2)-glycoprotein I deficiency. Blood. 2000; 96: 1594-1595. PMID: 10942413
6. Chiu WC, Chiou TJ, Chiang AN. β2 -Glycoprotein I inhibits endothelial cell migration through nuclear factor kB signaling pathway and endothelial nitric oxide synthase activation. Biochem J. 2012; 445: 125-133. doi: 10.1042/BJ20111383 PMID: 22489810
7. Alard JE, Gaillard F, Daridon C, Shoenfeld Y, Jamin C, Youinou P. TLR2 is one of the endothelial receptors for beta2-glycoprotein I. J Immunol. 2010; 185: 1550-1557. doi: 10.4049/jimmunol.1000526 PMID: 20601596
8. Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR. High affinity binding of beta2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem. 2000; 275: 15541-15548. PMID: 10809787
9. Eswarappa SM, Fox PL. Antiangiogenic VEGF-Ax: a new participant in tumor angiogenesis. Cancer Res. 2015; 75: 2765-2769. doi: 10.1158/0008-5472.CAN-14-3805 PMID: 26122849
10. Zhang Y, Han Q, Ru Y, Bo Q, Wei RH. Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application. Drug Des Devel Ther. 2015; 9: 3413-3421. doi: 10.2147/DDDT.S87920 PMID: 26170626
11. Chiu WC, Lin JY, Lee TS, You LR, Chiang AN. β2 -Glycoprotein I inhibits VEGF-induced endothelial cell growth and migration via suppressing phosphorylation of VEGFR2, ERK1/2 and Akt. Mol Cell Biochem. 2013; 372: 9-15. doi: 10.1007/s11010-012-1440-6 PMID: 22956423
12. Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature. 2005; 438: 967-974. PMID: 16355214
13. Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res. 2007; 100: 782-794. PMID: 17395884
14. Elshabrawy HA, Chen Z, Volin MV, Ravella S, Virupannavar S, Shahrara S. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis. 2015; 18: 433-448. doi: 10.1007/s10456-015-9477-2 PMID: 26198292
15. Esposito E, Hayakawa K, Maki T, Arai K, Lo EH. Effects of post conditioning on neurogenesis and angiogenesis during the recovery phase after focal cerebral ischemia. Stroke. 2015; 46: 2691-2694. doi: 10.1161/STROKEAHA.115.009070 PMID: 26243221
16. Jeong da E, Song HJ, Lim S, Lee SJ, Lim JE, Nam DH, et al. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis. Oncotarget. 2015; 6: 33046-33064. doi: 10.18632/oncotarget.5422 PMID: 26426994
17. Brönneke S, Brückner B, Söhle J, Siegner R, Smuda C, Stäb F, et al. Genome-wide expression analysis of wounded skin reveals novel genes involved in angiogenesis. Angiogenesis. 2015; 18: 361-371. doi: 10.1007/s10456-015-9472-7 PMID: 26018928
18. Tong Q, Qing Y, Wu Y, Hu X, Jiang L, Wu X. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways. Toxicol Appl Pharmacol. 2014; 281: 166-173. doi: 10.1016/j.taap.2014.07.026 PMID: 25111127
19. Bekhite MM, Finkensieper A, Binas S, Müller J, Wetzker R, Figulla HR, et al. VEGF-mediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells. J Cell Sci. 2011; 124: 1819-1830. doi: 10.1242/jcs.077594 PMID: 21540297
20. Kim BR, Seo SH, Park MS, Lee SH, Kwon Y, Rho SB. sMEK1 inhibits endothelial cell proliferation by attenuating VEGFR2-dependent Akt/eNOS/HIF-1α signaling pathways. Oncotarget. 2015; 6: 31830-31843. doi: 10.18632/oncotarget.5570 PMID: 26378810
21. Xu J, Yi Y, Li L, Zhang W, Wang J. Osteopontin induces vascular endothelial growth factor expression in articular cartilage through PI3K/AKT and ERK1/2 signaling. Mol Med Rep. 2015; 12: 4708-4712. doi: 10.3892/mmr.2015.3975 PMID: 26099282
22. Mai J, Qiu Q, Lin YQ, Luo NS, Zhang HF, Wen ZZ, et al. Angiotensin II-derived reactive oxygen species promote angiogenesis in human late endothelial progenitor cells through heme oxygenase-1 via ERK1/2 and AKT/PI3K pathways. Inflammation. 2014; 37: 858-870. doi: 10.1007/s10753-013-9806-9 PMID: 24442713
23. Lin KY, Wang HH, Lai ST, Pan JP, Chiang AN. β2 -glycoprotein I protects J774A.1 macrophages and human coronary artery smooth muscle cells against apoptosis. J Cell Biochem. 2005; 94: 485-496. PMID: 15534879
24. Chistiakov DA, Orekhov AN, Bobryshev YV. Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability. Acta Physiol (Oxf). 2015; 213: 539-553.
25. Rivera JC, Noueihed B, Omri S, Barrueco J, Hilberg F, Chemtob S. BIBF1120 (Vargatef) Inhibits preretinal neovascularization and enhances normal vascularization in a model of vasoproliferative retinopathy. Invest Ophthalmol Vis Sci. 2015; 56: 7897-7907. doi: 10.1167/iovs.15-17146 PMID: 26670826
26. Cao Z, Shang B, Zhang G, Miele L, Sarkar FH, Wang Z, et al. Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochim Biophys Acta. 2013; 1836: 273-286. doi: 10.1016/j.bbcan.2013.08.001 PMID: 23933263
27. 2-glycoprotein I-function in health and disease. Thromb Res. 2004; 114: 335-346. PMID: 15507263
28. Radziwon-Balicka A, Moncada de la Rosa C, Jurasz P. Platelet-associated angiogenesis regulating factors: a pharmacological perspective. Can J Physiol Pharmacol. 2012; 90: 679-688. doi: 10.1139/y2012-036 PMID: 22512504
29. Kondo J, Shibata H, Miura S, Yamakawa A, Sato K, Higuchi Y, et al. A functional role of the glycosylated N-terminal domain of chondromodulin-I. J Bone Miner Metab. 2011; 29: 23-30. doi: 10.1007/s00774-010-0193-0 PMID: 20506028
30. Santos IC, Silbiger VN, Higuchi DA, Gomes MA, Barcelos LS, Teixeira MM, et al. Angiostatic activity of human plasminogen fragments is highly dependent on glycosylation. Cancer Sci. 2010; 101: 453-459. doi: 10.1111/j.1349-7006.2009.01403.x PMID: 19961492
31. Kassaar O, McMahon SA, Thompson R, Botting CH, Naismith JH, Stewart AJ. Crystal structure of histidine-rich glycoprotein N2 domain reveals redox activity at an interdomain disulfide bridge: implications for angiogenic regulation. Blood. 2014; 123: 1948-1955. doi: 10.1182/blood-2013-11-535963 PMID: 24501222
32. Zabrenetzky V, Harris CC, Steeg PS, Roberts DD. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines. Int J Cancer. 1994; 59: 191-195. PMID: 7927918
33. Belotti D, Foglieni C, Resovi A, Giavazzi R, Taraboletti G. Targeting angiogenesis with compounds from the extracellular matrix. Int J Biochem Cell Biol. 2011; 43: 1674-1685. doi: 10.1016/j.biocel.2011.08.012 PMID: 21864705
34. Yu P, Passam FH, Yu DM, Denyer G, Krilis SA. Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. J Thromb Haemost. 2008; 6: 1215-1223. doi: 10.1111/j.1538-7836.2008.03000.x PMID: 18452581
35. Hunt JE, Simpson RJ, Krilis SA. Identification of a region of β2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc Natl Acad Sci (USA). 1993; 90: 2141-2145.
36. Wang SX, Cai GP, Sui SF. The insertion of human apolipoprotein H into phospholipid membranes: a monolayer study. Biochem J. 1998; 335: 225-232. PMID: 9761718
37. Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR. High affinity binding of beta2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem. 2000; 275: 15541-15548. PMID: 10809787
38. Itoh Y, Inuzuka K, Kohno I, Wada H, Shiku H, Ohkura N, et al. Highly increased plasma concentrations of the nicked form of beta(2) glycoprotein I in patients with leukemia and with lupus anticoagulant: measurement with a monoclonal antibody specific for a nicked form of domain V. J Biochem. 2000; 128: 1017-1024. PMID: 11098145
39. Cai G, Satoh T, Hoshi H. Purification and characterization of an endothelial cell-viability maintaining factor from fetal bovine serum. Biochim Biophys Acta. 1995; 1269: 13-18. PMID: 7578265
40. Ioannou Y, Zhang JY, Passam FH, Rahgozar S, Qi JC, Giannakopoulos B, et al. Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. Blood. 2010; 116: 1961-1970. doi: 10.1182/blood-2009-04-215335 PMID: 20551379
41. Passam FH, Qi JC, Tanaka K, Matthaei KI, Krilis SA. In vivo modulation of angiogenesis by beta 2 glycoprotein I. J Autoimmun. 2010; 35: 232-240. doi: 10.1016/j.jaut.2010.06.013 PMID: 20655705
42. Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, et al. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci (USA). 1997; 94: 10868-10872.
43. Sakai T, Balasubramanian K, Maiti S, Halder JB, Schroit AJ. Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis. Am J Pathol. 2007; 171: 1659-1669. PMID: 17872974
44. Beecken WD, Engl T, Ringel EM, Camphausen K, Michaelis M, Jonas D, et al. An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I. Ann Surg Oncol. 2006; 13: 1241-1251. PMID: 16955386
45. Nakagawa H, Yasuda S, Matsuura E, Kobayashi K, Ieko M, Kataoka H, et al. Nicked {beta}2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property. Blood. 2009; 114: 2553-2559. doi: 10.1182/blood-2008-12-190629 PMID: 19625706
46. Schuermann A, Helker CS, Herzog W. Metallothionein 2 regulates endothelial cell migration through transcriptional regulation of vegfc expression. Angiogenesis. 2015; 18: 463-475. doi: 10.1007/s10456-015-9473-6 PMID: 26198291
47. Tian R, Yang S, Zhu Y, Zou S, Li P, Wang J, et al. VEGF/VEGFR2 Signaling Regulates Germ Cell Proliferation in vitro and Promotes Mouse Testicular Regeneration in vivo. Cell Tissue Organ. 2016; 201: 1-13.
48. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci. 2007; 120: 964-972. PMID: 17311849
49. Delli Carpini J, Karam AK, Montgomery L. Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis. 2010; 13: 43-58. doi: 10.1007/s10456-010-9163-3 PMID: 20229258
50. Ruan GX, Kazlauskas A. VEGF-A engages at least three tyrosine kinases to activate PI3K/Akt. Cell Cycle. 2012; 11: 2047-2048. doi: 10.4161/cc.20535 PMID: 22647379
51. Ding Q, Tian XG, Li Y, Wang QZ, Zhang CQ. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway. World J Gastroenterol. 2015; 21: 9566-9576. doi: 10.3748/wjg.v21.i32.9566 PMID: 26327764
52. Iyer AK, Ramesh V, Castro CA, Kaushik V, Kulkarni YM, Wright CA, et al. Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF. J Cell Biochem. 2015; 116: 2484-2493. doi: 10.1002/jcb.25192 PMID: 25919965
53. Beecken WD, Ringel EM, Babica J, Oppermann E, Jonas D, Blaheta RA. Plasmin-clipped beta(2)-glycoprotein-I inhibits endothelial cell growth by down-regulating cyclin A, B and D1 and up-regulating p21 and p27. Cancer Lett. 2010; 296: 160-167. doi: 10.1016/j.canlet.2010.04.010 PMID: 20435405
54. Lee SJ, Namkoong S, Kim YM, Kim CK, Lee H, Ha KS, et al. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. Am J Physiol Heart Circ Physiol. 2006; 291: H2836-2846. PMID: 16877565
55. Chung BH, Kim JD, Kim CK, Kim JH, Won MH, Lee HS, et al. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochem Biophys Res Commun. 2008; 376: 404-408. doi: 10.1016/j.bbrc.2008.09.001 PMID: 18789310
56. Somanath PR, Razorenova OV, Chen J, Byzova TV. Akt1 in endothelial cell and angiogenesis. Cell Cycle. 2006; 5: 512-518. PMID: 16552185
57. Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998; 97: 99-107. PMID: 9443437
58. Noiri E, Lee E, Testa J, Quigley J, Colflesh D, Keese CR, et al. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol. 1998; 274: C236-244. PMID: 9458733
59. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol. 1996; 270: H411-415. PMID: 8769777
60. Bir SC, Xiong Y, Kevil CG, Luo J. Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases. Cardiovasc Res. 2012; 95: 7-18. doi: 10.1093/cvr/cvs143 PMID: 22492672
61. Huang D, Ding Y, Luo WM, Bender S, Qian CN, Kort E, et al. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo. Cancer Res. 2008; 68: 81-88. doi: 10.1158/0008-5472.CAN-07-5311 PMID: 18172299
62. Wang CY, Tsai AC, Peng CY, Chang YL, Lee KH, Teng CM, et al. Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3beta and mTOR signaling pathways. PLoS One 2012; 7: e31195. doi: 10.1371/journal.pone.0031195 PMID: 22359572